Asthma: epidemiology of disease control in Latin America - short review

Dirceu Solé1, Carolina Sanchez Aranda1, Gustavo Falbo Wandalsen1

  • 1Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Escola Paulista de Medicina, Federal University of São Paulo, Rua dos Otonis, 725 - Vila Clementino, 04025-002 São Paulo, Brazil.

Insights

Asthma remains poorly controlled in Latin America, particularly in children and adolescents, despite available guidelines. Enhanced patient and physician education is crucial to reduce the disease burden.

Area of Science:

  • Pulmonology
  • Epidemiology
  • Public Health

Background:

  • Asthma is a prevalent chronic childhood disease impacting quality of life and incurring significant healthcare costs.
  • Despite advancements in pharmacotherapy and international guidelines, asthma control remains suboptimal, especially within the Latin American region.
  • Poorly controlled asthma contributes to increased healthcare utilization, including emergency visits and hospitalizations, and a substantial societal burden.

Purpose of the Study:

  • To analyze the epidemiology and control of asthma in Latin America over the past two decades.
  • To identify unmet needs and challenges in asthma management for children, adolescents, and adults in the region.
  • To evaluate the prevalence, severity, and treatment patterns of asthma in Latin American populations.

Main Methods:

  • A systematic review and analysis of original and review articles published in PubMed-referenced journals over the last 20 years.
  • Keywords used included "asthma control" combined with "Latin America", "epidemiology", "prevalence", "burden", "mortality", "treatment and unmet needs", "children", "adolescents", and "infants".
  • Studies with high levels of evidence were selected for analysis.

Main Results:

  • A high prevalence and severity of asthma were observed, particularly affecting children and adolescents.
  • Wheezing in infants frequently led to medical consultations in Latin American health centers.
  • Frequent reliance on quick-relief bronchodilators and oral corticosteroids, alongside low adherence to anti-inflammatory medications in adults, indicates poor asthma control and inadequate care policies.

Conclusions:

  • Asthma control in Latin America is consistently inadequate, with patients often overestimating their condition control.
  • Significant gaps exist in asthma management, necessitating improved adherence to international treatment guidelines.
  • Enhanced educational initiatives for both healthcare providers and patients are essential to improve asthma control and mitigate its individual and societal impact.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K